Case-Based Review

Management of Plasma Cell Disorders


 

The plasma cell disorders are a spectrum of conditions that include asymptomatic precursor conditions—monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM)—as well as symptomatic multiple myeloma (MM) and solitary plasmacytoma. Other plasma cell disorders include immunoglobulin light chain amyloidosis and POEMS syndrome, which are characterized by a unique set of end-organ manifestations. There are other related plasma cell and B-cell proliferations, such as light chain deposition disease and cryoglobulinemia, that are beyond the scope of this review but are relevant to the hematologist/oncologist and have been reviewed in detail elsewhere.

To read the full article in PDF:

Click here

Recommended Reading

Classic HL vulnerable to PD-1 blockade therapy
MDedge Hematology and Oncology
Approach can cure even high-risk FL, study suggests
MDedge Hematology and Oncology
CKT more important than del(17p) in CLL, group finds
MDedge Hematology and Oncology
CHMP recommends bortezomib for MCL
MDedge Hematology and Oncology
Brentuximab combinations highly active in Hodgkin lymphoma
MDedge Hematology and Oncology
Study reveals superior antiviral drug for lymphoma
MDedge Hematology and Oncology
‘Father of hematopoietic cytokines’ dies
MDedge Hematology and Oncology
Reducing chemo drug’s cardiac side effects
MDedge Hematology and Oncology
Antibody shows activity in relapsed/refractory NHL
MDedge Hematology and Oncology
New data added to obinutuzumab label
MDedge Hematology and Oncology